RESTIT : Evaluation of Resorbable Osteosynthesis Devices Versus Titanium in Maxillofacial Surgery
1 other identifier
interventional
308
1 country
1
Brief Summary
Primary objective : To evaluate the quality of fractures setting and osteotomy of the facial massif osteosynthesised with resorbable device PLLA/PGA compared with usual Titanium plates. Secondary objective :
- To evaluate the resorbable device ergonomy versus Titanium.
- To evaluate the clinical tolerance of resorbable device versus Titanium. Hypothesis : Osteosynthesis with resorbable device demonstrates a non inferiority success probability regarding the success observed in osteosynthesis with Titanium, with a less important probability of re-operation. Study duration : 14 months for each patient. Study treatment :
- Group I : Resorbable device PLLA/PGA.
- Group II : Titanium device. Study visits : \- Screening visit - Baseline with randomization and surgery - Day1 - Day 21 - Day 45(Traumatology)/Day 90 (orthognatic) - Month 6,12 and 14. Randomization : Stratification by centres, mono or bimaxillar surgery and traumatologic or orthognatic criteria.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
October 14, 2005
CompletedFirst Posted
Study publicly available on registry
October 18, 2005
CompletedStudy Start
First participant enrolled
November 1, 2005
CompletedApril 27, 2007
April 1, 2007
October 14, 2005
April 26, 2007
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
The quality of fractures setting and osteotomy of the facial massif osteosynthesised with resorbable device PLLA/PGA will be evaluated by the notion of unperfect resuts.
Secondary Outcomes (8)
Evaluation of device ergonomy :
The operative time of each surgery will be monitored, to compare operative duration of operations ; the only variable will be the osteosynthesis method.
Clinical tolerance of the devices
pain (Visual Analogic Scale),
local inflammation,
- +3 more secondary outcomes
Interventions
Eligibility Criteria
You may qualify if:
- \<Age\<50.
- One or more fractures of facial massif requiring a surgical setting with osteosynthesis plates.
- One or more osteotomy of facial massif requiring a surgical setting with osteosynthesis plates.
- Orally and written informed patient. Patient willing to participate the study.
- Signed informed consent.
You may not qualify if:
- Any previous surgery at the same operative site.
- Patient suffering from chronic affection which could interfere with bone consolidation.
- Corticotherapy, immunosuppressive or anticonvulsant treatment or long term antibiotherapy.
- Nursing or pregnant female.
- Patient with a high risk of non compliance to sudy visits.
- Unconscious patient.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Pierre Bouletreau
Lyon, 69495, France
Study Officials
- PRINCIPAL INVESTIGATOR
Pierre BOULETREAU, MD
Hospices Civile de Lyon
Central Study Contacts
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- NONE
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
Study Record Dates
First Submitted
October 14, 2005
First Posted
October 18, 2005
Study Start
November 1, 2005
Last Updated
April 27, 2007
Record last verified: 2007-04